The Vietnamese pharmaceutical market: a comparison of foreign entry strategies
by Daniel Simonet
International Journal of Business and Emerging Markets (IJBEM), Vol. 1, No. 1, 2008

Abstract: Background. Entry strategies in the Vietnamese pharmaceutical market are under-researched. Aim. The first part of the paper provides an overview of the Vietnamese pharmaceutical market, and the second part a theoretical framework to understand the various foreign entry strategies. Methodology. Literature review and interviews with professionals. Contribution. Preference for one mode over another depends on market and company characteristics, the firm's objectives and risk aversion level. Recommendations. There are few joint ventures. Licensing and acquisition of a local drug firm appear risky owing to lack of IP rights and cultural clash. The long-term pay-offs of wholly owned subsidiaries are higher.

Online publication date: Thu, 03-Jul-2008

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Business and Emerging Markets (IJBEM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com